ライフサイエンスコーパス: DM

1 DM catalyzes peptide loading, whereas DO, an MHCII subst

2 DM increases the risk of developing TB and contributes t

3 DM input parameters were based on data from the Dutch br

4 DM screening examinations 1 year prior to DBT implementa

5 DM was significantly associated with increased knee pain

6 In a second model of type 1 DM, mice treated with streptozotocin (STZ) showed a simi

7 g abnormalities were observed for PM (100%), DM (100%), and SGA (42.9%) vs NSNM infants (18.3%; P <.0

8 Eligible studies consisted of 34 106 DM/DBT examinations between October 3, 2011, and October

9 at the University of Pennsylvania and 51 148 DM/DBT examinations between January 1, 2012, and May 31,

10 The mean duration of type-2 DM among individuals in group-1 was 8.2 years (7 to 10 y

11 Group-1: Patients with type-2 DM and CP; group-2: Non-diabetic individuals with CP; gr

12 f AGEs are higher in CP patients with type-2 DM compared to systemically healthy individuals with and

13 tients with type-2 diabetes mellitus (type-2 DM) than controls (systemically healthy individuals with

14 e GCF of CP patients with and without type-2 DM.

15 Overall, GCs were frequent after 3 (DM: 53.9%; EM: 69.2%) and 6 months (DM: 76.9%; EM: 88.5%

16 Results There were 56 839 DBT and 10 511 DM examinations.

17 Results The DM group consisted of 99 582 DM examinations in 55 086 women (mean age, 57.3 years +/

18 on in an isogenic lung model reveals >50,600 DM CpGs compared to non-transformed controls.

19 There were 183 989 DBT and 196 652 DM examinations.

20 ated 158 first HTX recipients (82 non-DM, 76 DM of whom 35 [46%] were receiving metformin).

21 FG >= 126 mg/dL, the use of DM medication, a DM diagnosis, or hemoglobin A1c >= 6.5%.

22 suggestive differential associations across DM trial arms, especially with respect to coronary heart

23 talytic turnover, suggesting that the active DM-pMHCII catalytic complex operates on pMHCII complexes

24 Age-adjusted DM prevalence was estimated using laboratory glycated he

25 rdiovascular events in patients with CAD and DM.

26 oxidase) levels, in comparison to DM+INS and DM+RSV+INS (P < 0.05).

27 associations between HOMA-B and HOMA-IR and DM by haplogroup.

28 grouped into subjects with both knee OA and DM (n = 148) or knee OA only without DM (n = 1171).

29 on showed that participants with knee OA and DM had 2.45 (95% CI 1.07-5.61) to 2.55 (95% CI 1.12-5.79

30 M was detached; and mixed, where the PDL and DM were detached but also separated from each other.

31 D were identified: type 1, where the PDL and DM were detached together; type 2, where only the DM was

32 is revealed greater bone loss in DM+PLAC and DM+INS in comparison to the other treatments (P < 0.05).

33 ng abnormalities were seen in 100% of PM and DM and in 42.9% of SGA vs NSNM infants 16%; (P <.001); O

34 relationship between insulin resistance and DM.

35 omized controlled trial comparing DBT+SM and DM was performed in Bergen as part of BreastScreen Norwa

36 The association between TB and DM was assessed.

37 etter clinical management of combined TB and DM.

38 n between the two production methods (TM and DM).

39 Human leukocyte antigen-DM (HLA-DM) is an integral component of the major histoc

40 We assessed DM status and clinical correlates in TB patients across

41 s (37.4% [72 of 191] vs 29.0% [52 of 179] at DM P = .35), but more radial sclerosing lesions (8.3% [9

42 rity, and to explore the association between DM and knee pain distribution (unilateral or bilateral v

43 y aimed at examining the association between DM and knee pain severity, and to explore the associatio

44 s in the cancer detection rate (CDR) between DM and DBT groups (4.6-5.8 per 1000 examinations, P = .0

45 Performance metrics were compared between DM and DBT groups and between patients with no previous

46 cerned in the agreement distribution between DM and TAD for TF (p < 0.001).

47 For TF and TSF, the IMR between DM and TAD was lower than MDM and TAD for consistency/ab

48 no difference in Sirius Red staining between DM and NDM tissues.

49 ue paralleling hyperglycemia in mice of both DM types.

50 nsitivity (DBT, 89.8% [966 of 1076 cancers]; DM, 85.6% [789 of 922 cancers]; P = .004) and specificit

51 sympathetic innervation is ongoing in canine DM and does not necessarily precede it.

52 In addition, in myeloid cell DM and DFU upstream regulator analysis, we observed inhi

53 upfront resection and adjuvant chemotherapy (DM 83.0%, LR 16.9%) regardless of margin-involvement (DM

54 t initiation contributed time until clinical DM (HbA1c >=6.5%, initiation of DM-specific medication,

55 severe TB, and more frequent comorbidities, DM complications, and hypertension (P value < .05).

56 Overall, 722 (3%) developed DM.

57 Obesity-related type 2 diabetes (DM) is a major public health concern.

58 association at enrollment in newly diagnosed DM, but persistent hyperglycemia and TB/DM association i

59 Compared to those with newly diagnosed DM, TB patients with diagnosed DM had higher BMI and HbA

60 wly diagnosed DM, TB patients with diagnosed DM had higher BMI and HbA1c, less severe TB, and more fr

61 of the nonclassical MHCII molecules, HLA-DM (DM) and HLA-DO (DO).

62 During DM, cardioprotection induced by conventional pre-conditi

63 (SF-PreCon) remains cardioprotective during DM, and identified the involved mechanisms.

64 dothelium complex (DEC) was retrieved during DM endothelial keratoplasty (DMEK) surgery.

65 osatellite expansions in myotonic dystrophy (DM), is essential for normal thymus development and func

66 BT, 90.7% [165 830 of 182 913 examinations]; DM, 89.1% [174 480 of 195 730 examinations]; P < .001) w

67 ll methods at all levels (p < 0.001), except DM and TAD for TF (p = 0.622).

68 he three spectrometers were 5.2 +/- 0.9% for DM, 8.4 +/- 1.5% for SS, 27.6 +/- 2.0% for FF and 8.0 +/

69 BT vs 7.9% [6742 of 85 254 examinations] for DM/DBT; P < .01).

70 The reliability measure for DM and MDM was higher than MDM and TAD for TSF, but was

71 The ICC measure for DM-TAD was significantly lower than DM-MDM and MDM-TAD (

72 d with denser breasts for DBT+SM but not for DM.

73 DG, whereas no differences were observed for DM (relative risk of recall for VDG 2: 1.3; P = .06; VDG

74 d a significantly higher odds ratio (OR) for DM in men aged 64 years or younger (OR [95% confidence i

75 All participants were screened for DM using glycated hemoglobin and fasting plasma glucose

76 ough overall malignancy rate was similar for DM-guided biopsy (27.8% [179 of 643]) and DBT-guided bio

77 f extracellular vesicles (EVs) isolated from DM mice and enhanced presence of TJ proteins, occludin a

78 ion in sPanc in dogs that do not suffer from DM links the disease in the exocrine pancreas to a patho

79 oss DBT rounds were compared with those from DM rounds by using logistic regression to account for ex

80 ated fructan-levels, in oat malt 0.8 g/100 g DM fructans were de novo synthesized.

81 act (6.97 umol chenodesoxycholic acids/100 g DM) that was rich in phytochemicals, such as flavonoids

82 chemicals, such as flavonoids (1842 mg/100 g DM).

83 enodesoxycholic acids (up to 2.33 umol/100 g DM).

84 yphenol concentrations in crude (488.93mug/g DM) and purified (8394.99mug/g DM) extracts.

85 (488.93mug/g DM) and purified (8394.99mug/g DM) extracts.

86 fied extracts (71.83 and 87.78mumol Trolox/g DM).

87 ive male rats were divided into five groups: DM+PLAC: Diabetes Mellitus + placebo solution; DM+INS: D

88 d not alter pattern of recurrence; 81.7% had DM and 18.3% had LR.

89 HLA-DM shapes the immune system by differentially catalyzing

90 Human leukocyte antigen-DM (HLA-DM) is an integral component of the major histocompatibi

91 lay of the nonclassical MHCII molecules, HLA-DM (DM) and HLA-DO (DO).

92 nover, independent kinetic parameters of HLA-DM enzymatic activity.

93 ytic complex and the binding affinity of HLA-DM for a pMHCII.

94 ntify difference in elasticity between human DM and non-diabetic (NDM) visceral adipose tissue.

95 We assessed the prevalence of hyperglycemia (DM and impaired glucose regulation [IGR]) in persons wit

96 In DM and AMPK-DN mice, the inhibitory effect of SF-PreCon

97 In DM screening, 24.6% (n = 44) patients were FINDRISC+, in

98 In DM-PSI preparations excited at 740 nm, the excitation re

99 gressive cardiomyocyte lipid accumulation in DM but not in non-DM recipients (p = 0.019).

100 e for SF-PreCon mediated cardioprotection in DM mice, cell survival molecules were screened.

101 mpaired migratory profile of immune cells in DM skin.

102 revealed increased hydroxyproline content in DM adipose tissue, but no difference in Sirius Red stain

103 peutic approach to avert cognitive demise in DM.

104 as long-term chronic disease development in DM trial participants (n ~ 5000).

105 by increased elastic modulus, is enhanced in DM adipose tissue, and suggest that measures of tissue m

106 an intronic CCTG microsatellite expansion in DM type 2 (DM2), is coordinately expressed with MBNL1 in

107 ated biopsies of healthy implanted hearts in DM recipients during 12-month follow-up from HTX.

108 omyocyte lipid accumulation following HTX in DM recipients.

109 rdingly, lipotoxic factors were increased in DM versus non-DM recipients, and, relevantly, metformin

110 SF-PreCon markedly reduced MI/R injury in DM mice, as evidenced by improved cardiac function (incr

111 etric analysis revealed greater bone loss in DM+PLAC and DM+INS in comparison to the other treatments

112 horylation of ERK1/2, a pro-survival MAPK in DM and AMPK-DN mice.

113 activation of a pro-survival MAPK member in DM mice.

114 olysis and basal respiration were reduced in DM, and glycolysis was increased by metformin.

115 including fibrosis, plays a central role in DM pathogenesis.

116 ding on the presence of absence of a tear in DM or both layers.

117 Incident DM was defined by a combination of FG >= 126 mg/dL, the

118 We compared HOMA-B, HOMA-IR, and incident DM by haplogroups and assessed the associations between

119 ciated with beta-cell functions and incident DM in non-Hispanic, Black women with HIV and alters the

120 95% confidence intervals ([-]) for incident DM by cART class.

121 sons starting INSTIs vs. NNRTIs had incident DM risk (HR=1.17 [0.92-1.48]) similar to PI- vs. NNRTI-i

122 initial cART regimen and weight on incident DM in a large North American HIV cohort (NA-ACCORD).

123 The impact of HOMA-IR on incident DM was less significant in those with haplogroup L2, com

124 Streptozotocin was used to induce DM and EP was induced by the placement of a ligature at

125 al diet (ND) and high-fat diet (HFD)-induced DM mice were randomized into control and SF-PreCon (3 cy

126 titis (sPanc), both (sDMPanc), toxin-induced DM (iDM) and controls.

127 DO protein levels yet efficiently inhibited DM activity.

128 iabetes Mellitus + placebo solution; DM+INS: DM + insulin therapy; DM+RSV: DM + RSV; DM+RSV+INS: DM +

129 sulin therapy; DM+RSV: DM + RSV; DM+RSV+INS: DM + RSV and insulin; NDM: non-diabetic.

130 The INSTI-DM association was attenuated (HR=1.03 [0.71-1.49] vs. N

131 LR 16.9%) regardless of margin-involvement (DM 80.1%, LR 19.4%).

132 consistent regardless of margin-involvement (DM 94.1%, LR 5.9%).

133 >= 5.7%), including those with already known DM.

134 including all patients with currently known DM (21 of 21).

135 An exciting possibility is that the known, DM-mediated coupling between chirality and crystal latti

136 ically, we leverage droplet magnetofluidics (DM) to automate the movement of magnetic beads between s

137 considered superior to digital mammography (DM) for women with dense breasts.

138 ing, when compared with digital mammography (DM) in the Netherlands, and to quantify the uncertainty.

139 sis (DBT) combined with digital mammography (DM) is increasingly used in the United States instead of

140 phy (SM) or standard 2D digital mammography (DM) results in detection of more breast cancers than doe

141 d rounds to outcomes of digital mammography (DM) screening.

142 breast center that used digital mammography (DM) stereotactic guidance from 2013 to 2015 and DBT-guid

143 ith those obtained with digital mammography (DM); however, the impact of DBT on patient survival has

144 y 2011, two-dimensional digital mammography [DM] group) and for 5 years after implementation (January

145 ion-makers encode the disincentive markdown (DM) more strongly.

146 Squares regression to determine dry matter (DM), soluble solids (SS), flesh firmness (FF) and skin c

147 tibodies against AGEs and diabetes mellitus (DM 44% vs 24.4%; p = 0.05).

148 Canine diabetes mellitus (DM) affects 0.6% of the canine population and yet, its e

149 sal skin of patients with diabetes mellitus (DM) and DFU specimens compared with control subjects.

150 d the association between diabetes mellitus (DM) and knee pain in people with osteoarthritis (OA).

151 tion between incidence of diabetes mellitus (DM) and living conditions has not been studied after nat

152 Patients with diabetes mellitus (DM) are characterized by enhanced thrombotic risk attrib

153 ed a screening method for diabetes mellitus (DM) in patients with Stage III or IV periodontitis using

154 Diabetes mellitus (DM) increases tuberculosis (TB) risk.

155 art transplanted (HTX) in diabetes mellitus (DM) recipients, this study conducted a serial study of h

156 Diabetes mellitus (DM) significantly increases myocardial ischemia/reperfus

157 y group 1:2 based on sex, diabetes mellitus (DM) status, region of the United States, and Charleston

158 -IR), as well as incident diabetes mellitus (DM), among Black women living with or at risk for HIV.

159 gnosed with hypertension, diabetes mellitus (DM), and cancer before.

160 y disease (COPD), asthma, diabetes mellitus (DM), and end-stage renal disease (ESRD) were calculated

161 lic consequences, such as diabetes mellitus (DM), are unclear.

162 gnosed before KC included diabetes mellitus (DM), asthma, allergic rhinitis, mitral valve prolapse, c

163 years and a diagnosis of diabetes mellitus (DM).

164 ell-known complication of diabetes mellitus (DM).

165 tion (AF) is prevalent in diabetes mellitus (DM); however, the basis for this is unknown.

166 , of which the top 3 were diabetes mellitus (DM, 11.52%), eye trauma (10.55%), and dry eye (8.72%).

167 f collagen composition of Descemet membrane (DM) in advanced Fuchs endothelial corneal dystrophy (FEC

168 as locoregional (LR) or distant metastasis (DM).

169 (traditional method - TM and direct method - DM) used to produce shalgams were compared with respect

170 Inference of differentially methylated (DM) CpG sites between two groups of tumor samples with d

171 Differentially methylated (DM) loci in motile sperm were identified using reduced r

172 mechanisms, the formation of double minute (DM) chromosomes and breakage-fusion-bridge (BFB) cycles,

173 ealth Initiative (WHI) Dietary Modification (DM) clinical trial that evaluated a low-fat dietary patt

174 t participating in the dietary modification (DM) trial, which focused on the reduction of dietary fat

175 and nine with increased ability to modulate DM activity.

176 ractions at the peptide C terminus modulated DM-binding affinity, suggesting distal communication bet

177 after 3 (DM: 53.9%; EM: 69.2%) and 6 months (DM: 76.9%; EM: 88.5%).

178 e and its response to Dzyaloshinskii-Moriya (DM) interactions adhere to classical expectations.

179 pace closure initiation ("delayed movement," DM), whereas the contralateral premolar was extracted 1

180 In the presence of MS, DM, and HT, the presence of RSL was at a significantly h

181 initiation of DM-specific medication, or new DM diagnosis plus DM-related medication), virologic fail

182 ) evaluated 158 first HTX recipients (82 non-DM, 76 DM of whom 35 [46%] were receiving metformin).

183 cyte lipid accumulation in DM but not in non-DM recipients (p = 0.019).

184 By using a nondiabetic mellitus (non-DM) heart transplanted (HTX) in diabetes mellitus (DM) r

185 oxic factors were increased in DM versus non-DM recipients, and, relevantly, metformin use was associ

186 h groups, constituting 89.9% (578 of 643) of DM-guided biopsies and 71.1% (542 of 762) of DBT-guided

187 pancreatic cells, gene ontology analyses of DM promoters show an enrichment for genes involved in di

188 e exocrine pancreas is not a likely cause of DM in these dogs.

189 mor samples will lead to biased discovery of DM sites if not properly accounted for.

190 ding to our results, neither the duration of DM nor the presence of diabetic retinopathy did have a s

191 ith significant variability in elasticity of DM compared to NDM adipose tissue.

192 g to a fibrillar layer burying the guttae of DM in 84% (42/50) of DECs.

193 We compared the incidence of DM between individuals living in temporary housing (TH)

194 til clinical DM (HbA1c >=6.5%, initiation of DM-specific medication, or new DM diagnosis plus DM-rela

195 asingly used in the United States instead of DM alone for breast cancer screening.

196 The mean elastic modulus of DM adipose tissue was twice that of NDM adipose tissue (

197 We calculated the odds ratio of new onset of DM in the TH group (n = 2,372) compared with the non-TH

198 or PIs vs. NNRTIs may confer greater risk of DM, likely mediated through weight gain.

199 The type of DM (type 1 vs. type 2) did not influence the rate of pos

200 a combination of FG >= 126 mg/dL, the use of DM medication, a DM diagnosis, or hemoglobin A1c >= 6.5%

201 BAC rate, we found remarkable variability of DM across hospitals.

202 ds Retrospective analysis included 1 year of DM and 5 years of DBT screening (September 2011 to Septe

203 Microvascular compromise was described one DM complication.

204 ared to be at an increased risk of new onset DM.

205 patients with hyperlipidemia, depression, or DM were less likely to have KC, and patients with asthma

206 en screened with DBT and SM (study group) or DM alone (control group) between February 2014 and Decem

207 bacterial DNA into a PCR solution using our DM-based sample preparation.

208 Overall DM prevalence was 11.9% (95% confidence interval [CI], 9

209 pecific medication, or new DM diagnosis plus DM-related medication), virologic failure, cART regimen

210 PM, DM, or SGA classification was based on head circumferenc

211 n of first recurrence remained predominantly DM (66.6%) versus LR (33.3%) and remained consistent ind

212 Pattern of recurrence remained predominantly DM (88.9%) versus LR (11.1%).

213 nt at enrollment in both new and preexisting DM, but only persisted at follow-up in preexisting DM in

214 atients with HIV-1 infection and preexisting DM, despite TB therapy.

215 t only persisted at follow-up in preexisting DM in patients with HIV-1 infection.

216 ereas DO, an MHCII substrate mimic, prevents DM from interacting with MHCII, resulting in an altered

217 by silver(I) triflate in the presence of (R)-DM-SEGPHOS is reported.

218 were lower in PLAC when compared to DM+RSV, DM+RSV+INS and NDM (P < 0.05).

219 ution; DM+INS: DM + insulin therapy; DM+RSV: DM + RSV; DM+RSV+INS: DM + RSV and insulin; NDM: non-dia

220 INS: DM + insulin therapy; DM+RSV: DM + RSV; DM+RSV+INS: DM + RSV and insulin; NDM: non-diabetic.

221 FN examinations (DBT, 0.4 per 1000 screens; DM, 0.5 per 1000 screens; P = .21).

222 FN examinations (DBT, 0.6 per 1000 screens; DM, 0.7 per 1000 screens; P = .20) and symptomatic FN ex

223 h dense breasts (DBT, 0.14 per 1000 screens; DM: 0.07 per 1000 screens; P = .07).

224 l n-dodecyl-beta-D-maltoside solubilization (DM-PSI) and a, to our knowledge, new detergent-free meth

225 +PLAC: Diabetes Mellitus + placebo solution; DM+INS: DM + insulin therapy; DM+RSV: DM + RSV; DM+RSV+I

226 reatic islets of adult dogs with spontaneous DM (sDM), spontaneous pancreatitis (sPanc), both (sDMPan

227 to delineate the pMHCII intrinsic stability, DM-binding affinity, and catalytic turnover, independent

228 Age-standardized DM prevalence ranged from 10.9% (South Africa) to 19.7%

229 e-blind, placebo-controlled trial (the SUGAR-DM-HF trial [Studies of Empagliflozin and Its Cardiovasc

230 In the patients with T2D (DM), multifunctionality of circulating CD8 + PD-1 + T ce

231 st that can be used as an alternative to TAD/DM for determining TF/TSF in CFD.

232 In Taiwan, DM, eye trauma, and dry eye were key predisposing factor

233 Median HbA1c in TB-DM patients ranged from 7.4% (Romania) to 11.3% (Indones

234 revalence and clinical characteristics of TB-DM vary across settings.

235 a is often severe, and many patients with TB-DM have significant cardiovascular disease risk and seve

236 TB/DM association was significant at enrollment (odds ratio

237 osed DM, but persistent hyperglycemia and TB/DM association in patients with HIV-1 infection and pree

238 transient hyperglycemia and a significant TB/DM and TB/IGR association at enrollment in newly diagnos

239 The TB/DM association was significant at enrollment in both new

240 per 1000 women screened; 33 of 56 839) than DM (0.9 per 1000 women screened; 0.4, 1.6 per 1000 women

241 sure for DM-TAD was significantly lower than DM-MDM and MDM-TAD (p < 0.05).

242 This study found that DM was associated with higher pain severity and unilater

243 We show that DM prevalence and clinical characteristics of TB-DM vary

244 peptide interactions with the MHCII and the DM-pMHCII binding interface.

245 esults imply an intimate linkage between the DM-pMHCII interface and peptide-MHCII interactions throu

246 idence interval [CI]: 7.7, 8.2) than for the DM group (10.4%, 1094 of 10 511; 95% CI: 9.8, 11.0) (P <

247 or the DBT group, and 57 years +/-11 for the DM group.

248 th the rate of peptide dissociation from the DM-pMHCII catalytic complex and the binding affinity of

249 re detached together; type 2, where only the DM was detached; and mixed, where the PDL and DM were de

250 Results The DM group consisted of 99 582 DM examinations in 55 086 w

251 This study demonstrated that the DM provided higher phenolic and antioxidant potential th

252 to P(700) occurred at ~36 ps, similar to the DM-PSI.

253 Compared with the DM group, the DBT1 group had a lower abnormal interpreta

254 cebo solution; DM+INS: DM + insulin therapy; DM+RSV: DM + RSV; DM+RSV+INS: DM + RSV and insulin; NDM:

255 acceptable non-radiation dose alternative to DM.PurposeTo compare multicenter outcomes from breast ca

256 A levels were lower in PLAC when compared to DM+RSV, DM+RSV+INS and NDM (P < 0.05).

257 ase (NADPH oxidase) levels, in comparison to DM+INS and DM+RSV+INS (P < 0.05).

258 ncreatitis might be a potential precursor to DM.

259 To better understand DM selectivity, here we developed a real-time fluorescen

260 underwent 1405 breast biopsies: 643 by using DM (August 2013 to July 2015) (median age, 56 years; int

261 rates, and PPV1 were improved for DBT versus DM (P <= .001).

262 , or sensitivity (P = .33) for SM/DBT versus DM/DBT overall or within either institution (P > .05 for

263 m breast cancer screening with SM/DBT versus DM/DBT.Materials and MethodsThis was a retrospective stu

264 es, and improved performance outcomes versus DM.

265 The outcomes were compared for DBT+SM versus DM by VDG in descriptive analyses.

266 mammography (SM) (hereafter, DBT+SM) versus DM.

267 The pattern of recurrence was DM in 81.9% of patients, versus LR in 11.1%.

268 In the WHI DM trial, 48,835 postmenopausal women, ages 50-79 years,

269 th DM II were included in the study, 36 with DM without DR, 53 with mild NPDR, and 22 with moderate N

270 rdance rate was 1.4% (95% CI: 1.0, 2.7) with DM-guided biopsy and 4.5% (95% CI: 3.2, 6.3) with DBT-gu

271 respective CMC, except for older adults with DM or those aged <65 years with CVA.

272 193), followed over lifetime, compared with DM and led to 2% (four of 159) fewer false-positive resu

273 h RR and CDR remained improved compared with DM for 5 years of DBT at the population level.

274 202], euro 263 537 [$289 891]) compared with DM, resulting in a mean incremental cost-effectiveness r

275 a slightly higher recall rate compared with DM/DBT (adjusted odds ratio [OR], 1.06; adjusted 95% CI:

276 ith slightly lower specificity compared with DM/DBT (adjusted OR, 0.95; adjusted 95% CI: 0.90, 0.99;

277 accumulation was reduced in comparison with DM recipients not receiving the drug (hazard ratio: 6.59

278 ability of a pMHCII linearly correlates with DM catalytic turnover, but is nonlinearly correlated wit

279 term antithrombotic therapy in patients with DM and CAD.

280 k of thrombotic complications, patients with DM commonly achieve enhanced absolute benefit from more

281 A total of 111 patients with DM II were included in the study, 36 with DM without DR,

282 In patients with DM with established CAD, secondary prevention with antip

283 In patients with DM without established CAD, primary prevention with aspi

284 of antithrombotic therapy for patients with DM.

285 DBT+SM and 14 369 of whom were screened with DM (both groups: median age, 59 years; interquartile ran

286 age limit, were consecutively screened with DM after 2 years.

287 d with DBT and SM versus those screened with DM alone and (b) screen-detected breast cancer at consec

288 eened with DBT+SM versus those screened with DM for VDG 1 (2.1% [81 of 3929] vs 3.3% [106 of 3212]; P

289 ears +/- 5) were consecutively screened with DM.

290 DBT and SM compared with women screened with DM.

291 mean age, 59 years +/- 6) were screened with DM.

292 more breast cancers than does screening with DM alone.

293 breast cancer at consecutive screenings with DM.

294 recall rate was lower with SM/DBT than with DM/DBT (7.0% [4630 of 66 109 examinations] for SM/DBT vs

295 OA and DM (n = 148) or knee OA only without DM (n = 1171).

296 aracteristics of TB patients with or without DM were compared using multilevel mixed-effect regressio

297 cardiovascular events than patients without DM, both before and after coronary artery disease (CAD)

298 l and bilateral knee pain than those without DM and without knee pain.

299 botic approaches compared with those without DM, which most often occurs at the expense of increased

300 Women without DM who had fasting glucose (FG) and insulin (FI) data fo